166 related articles for article (PubMed ID: 31526779)
1. Intramyocardial Bone Marrow Stem Cells in Patients Undergoing Cardiac Surgical Revascularization.
Chan JL; Miller JG; Zhou Y; Robey PG; Stroncek DF; Arai AE; Sachdev V; Horvath KA
Ann Thorac Surg; 2020 Apr; 109(4):1142-1149. PubMed ID: 31526779
[TBL] [Abstract][Full Text] [Related]
2. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
Karantalis V; DiFede DL; Gerstenblith G; Pham S; Symes J; Zambrano JP; Fishman J; Pattany P; McNiece I; Conte J; Schulman S; Wu K; Shah A; Breton E; Davis-Sproul J; Schwarz R; Feigenbaum G; Mushtaq M; Suncion VY; Lardo AC; Borrello I; Mendizabal A; Karas TZ; Byrnes J; Lowery M; Heldman AW; Hare JM
Circ Res; 2014 Apr; 114(8):1302-10. PubMed ID: 24565698
[TBL] [Abstract][Full Text] [Related]
3. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
[TBL] [Abstract][Full Text] [Related]
4. Intramyocardial injection of autologous bone marrow cells as an adjunctive therapy to incomplete myocardial revascularization--safety issues.
Gowdak LH; Schettert IT; Baptista E; Lopes NL; Rochitte CE; Vieira ML; Grupi CJ; César LA; Krieger JE; de Oliveira SA
Clinics (Sao Paulo); 2008 Apr; 63(2):207-14. PubMed ID: 18438575
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Effect of Transmyocardial Revascularization and Platelet-Rich Plasma on Improving Cardiac Function After Coronary Artery Bypass Grafting.
Khalpey Z; Kumar U; Aslam U; Deckwa J; Konhilas J
Cureus; 2024 May; 16(5):e60254. PubMed ID: 38872704
[TBL] [Abstract][Full Text] [Related]
6. Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.
Guijarro D; Lebrin M; Lairez O; Bourin P; Piriou N; Pozzo J; Lande G; Berry M; Le Tourneau T; Cussac D; Sensebe L; Gross F; Lamirault G; Huynh A; Manrique A; Ruidavet JB; Elbaz M; Trochu JN; Parini A; Kramer S; Galinier M; Lemarchand P; Roncalli J
Int J Cardiol; 2016 Apr; 209():258-65. PubMed ID: 26901787
[TBL] [Abstract][Full Text] [Related]
7. Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting.
Can A; Ulus AT; Cinar O; Topal Celikkan F; Simsek E; Akyol M; Canpolat U; Erturk M; Kara F; Ilhan O
Stem Cell Rev Rep; 2015 Oct; 11(5):752-60. PubMed ID: 26123356
[TBL] [Abstract][Full Text] [Related]
8. Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery.
Thielmann M; Massoudy P; Jaeger BR; Neuhäuser M; Marggraf G; Sack S; Erbel R; Jakob H
Eur J Cardiothorac Surg; 2006 Jul; 30(1):117-25. PubMed ID: 16723243
[TBL] [Abstract][Full Text] [Related]
9. Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up.
Mathiasen AB; Haack-Sørensen M; Jørgensen E; Kastrup J
Int J Cardiol; 2013 Dec; 170(2):246-51. PubMed ID: 24211066
[TBL] [Abstract][Full Text] [Related]
10. [Transmyocardial laser revascularization--a treatment option for coronary heart disease?].
Nägele H; Kalmar P; Lübeck M; Marcsek P; Nienaber CA; Rödiger W; Stiel GM; Stubbe HM
Z Kardiol; 1997 Mar; 86(3):171-8. PubMed ID: 9173706
[TBL] [Abstract][Full Text] [Related]
11. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease.
Lauer B; Junghans U; Stahl F; Kluge R; Oesterle SN; Schuler G
J Am Coll Cardiol; 1999 Nov; 34(6):1663-70. PubMed ID: 10577553
[TBL] [Abstract][Full Text] [Related]
12. The combined use of transmyocardial laser revascularisation and intramyocardial injection of bone-marrow derived stem cells in patients with end-stage coronary artery disease: one year follow-up.
Konstanty-Kalandyk J; Piątek J; Miszalski-Jamka T; Rudziński P; Walter Z; Bartuś K; Urbańczyk-Zawadzka M; Sadowski J
Kardiol Pol; 2013; 71(5):485-92. PubMed ID: 23788089
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
14. Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: initial results from a prospective phase I multicenter trial.
Assmann A; Heke M; Kröpil P; Ptok L; Hafner D; Ohmann C; Martens A; Karluβ A; Emmert MY; Kutschka I; Sievers HH; Klein HM
PLoS One; 2014; 9(7):e101449. PubMed ID: 25000346
[TBL] [Abstract][Full Text] [Related]
15. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
[TBL] [Abstract][Full Text] [Related]
16. Functional recovery of patients with ischemic cardiomyopathy treated with coronary artery bypass surgery and concomitant intramyocardial bone marrow mononuclear cell implantation--a long-term follow-up study.
Trifunović Z; Obradović S; Balint B; Ilić R; Vukić Z; Šišić M; Kostić J; Rusović S; Dobrić M; Ostojić G
Vojnosanit Pregl; 2015 Mar; 72(3):225-32. PubMed ID: 25958473
[TBL] [Abstract][Full Text] [Related]
17. Transmyocardial laser revascularization: a review of basic and clinical aspects.
Szatkowski A; Ndubuka-Irobunda C; Oesterle SN; Burkhoff D
Am J Cardiovasc Drugs; 2002; 2(4):255-66. PubMed ID: 14727971
[TBL] [Abstract][Full Text] [Related]
18. Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy.
Chin SP; Poey AC; Wong CY; Chang SK; Teh W; Mohr TJ; Cheong SK
Cytotherapy; 2010; 12(1):31-7. PubMed ID: 19878080
[TBL] [Abstract][Full Text] [Related]
19. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
[TBL] [Abstract][Full Text] [Related]
20. Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: preliminary results in a highly selected small patient cohort.
Babin-Ebell J; Sievers HH; Charitos EI; Klein HM; Jung F; Hellberg AK; Depping R; Sier HA; Marxsen J; Stoelting S; Kraatz EG; Wagner KF
Thorac Cardiovasc Surg; 2010 Feb; 58(1):11-6. PubMed ID: 20072970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
